389 related articles for article (PubMed ID: 11119611)
1. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53.
Rivas C; Thlick AE; Parravicini C; Moore PS; Chang Y
J Virol; 2001 Jan; 75(1):429-38. PubMed ID: 11119611
[TBL] [Abstract][Full Text] [Related]
2. p53 inhibition by the LANA protein of KSHV protects against cell death.
Friborg J; Kong W; Hottiger MO; Nabel GJ
Nature; 1999 Dec 23-30; 402(6764):889-94. PubMed ID: 10622254
[TBL] [Abstract][Full Text] [Related]
3. Recruitment of the tumour suppressor protein p73 by Kaposi's Sarcoma Herpesvirus latent nuclear antigen contributes to the survival of primary effusion lymphoma cells.
Santag S; Jäger W; Karsten CB; Kati S; Pietrek M; Steinemann D; Sarek G; Ojala PM; Schulz TF
Oncogene; 2013 Aug; 32(32):3676-85. PubMed ID: 22964633
[TBL] [Abstract][Full Text] [Related]
4. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with human myeloid cell nuclear differentiation antigen induced by interferon alpha.
Fukushi M; Higuchi M; Oie M; Tetsuka T; Kasolo F; Ichiyama K; Yamamoto N; Katano H; Sata T; Fujii M
Virus Genes; 2003 Dec; 27(3):237-47. PubMed ID: 14618084
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function.
Si H; Robertson ES
J Virol; 2006 Jan; 80(2):697-709. PubMed ID: 16378973
[TBL] [Abstract][Full Text] [Related]
6. Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures.
Ciufo DM; Cannon JS; Poole LJ; Wu FY; Murray P; Ambinder RF; Hayward GS
J Virol; 2001 Jun; 75(12):5614-26. PubMed ID: 11356969
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the bipartite nuclear localization signal of protein LANA2 from Kaposi's sarcoma-associated herpesvirus.
Muñoz-Fontela C; Rodríguez E; Nombela C; Arroyo J; Rivas C
Biochem J; 2003 Sep; 374(Pt 2):545-50. PubMed ID: 12767255
[TBL] [Abstract][Full Text] [Related]
8. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
Parravicini C; Chandran B; Corbellino M; Berti E; Paulli M; Moore PS; Chang Y
Am J Pathol; 2000 Mar; 156(3):743-9. PubMed ID: 10702388
[TBL] [Abstract][Full Text] [Related]
9. The KSHV latency-associated nuclear antigen: a multifunctional protein.
Komatsu T; Ballestas ME; Barbera AJ; Kaye KM
Front Biosci; 2002 Mar; 7():d726-30. PubMed ID: 11861213
[TBL] [Abstract][Full Text] [Related]
10. The latency protein LANA2 from Kaposi's sarcoma-associated herpesvirus inhibits apoptosis induced by dsRNA-activated protein kinase but not RNase L activation.
Esteban M; García MA; Domingo-Gil E; Arroyo J; Nombela C; Rivas C
J Gen Virol; 2003 Jun; 84(Pt 6):1463-1470. PubMed ID: 12771415
[TBL] [Abstract][Full Text] [Related]
11. Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus.
Chiou CJ; Poole LJ; Kim PS; Ciufo DM; Cannon JS; ap Rhys CM; Alcendor DJ; Zong JC; Ambinder RF; Hayward GS
J Virol; 2002 Apr; 76(7):3421-39. PubMed ID: 11884567
[TBL] [Abstract][Full Text] [Related]
12. Identification of a nuclear export signal in the KSHV latent protein LANA2 mediating its export from the nucleus.
Muñoz-Fontela C; Collado M; Rodriguez E; García MA; Alvarez-Barrientos A; Arroyo J; Nombela C; Rivas C
Exp Cell Res; 2005 Nov; 311(1):96-105. PubMed ID: 16214130
[TBL] [Abstract][Full Text] [Related]
13. Triptolide decreases expression of latency-associated nuclear antigen 1 and reduces viral titers in Kaposi's sarcoma-associated and herpesvirus-related primary effusion lymphoma cells.
Long C; Guo W; Zhou H; Wang J; Wang H; Sun X
Int J Oncol; 2016 Apr; 48(4):1519-30. PubMed ID: 26821279
[TBL] [Abstract][Full Text] [Related]
14. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA.
Ballestas ME; Kaye KM
J Virol; 2001 Apr; 75(7):3250-8. PubMed ID: 11238851
[TBL] [Abstract][Full Text] [Related]
15. Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.
Renne R; Barry C; Dittmer D; Compitello N; Brown PO; Ganem D
J Virol; 2001 Jan; 75(1):458-68. PubMed ID: 11119614
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with multifunctional angiogenin to utilize its antiapoptotic functions.
Paudel N; Sadagopan S; Chakraborty S; Sarek G; Ojala PM; Chandran B
J Virol; 2012 Jun; 86(11):5974-91. PubMed ID: 22438557
[TBL] [Abstract][Full Text] [Related]
17. Induction of paclitaxel resistance by the Kaposi's sarcoma-associated herpesvirus latent protein LANA2.
Muñoz-Fontela C; Marcos-Villar L; Hernandez F; Gallego P; Rodriguez E; Arroyo J; Gao SJ; Avila J; Rivas C
J Virol; 2008 Feb; 82(3):1518-25. PubMed ID: 18032494
[TBL] [Abstract][Full Text] [Related]
18. Altered patterns of cellular gene expression in dermal microvascular endothelial cells infected with Kaposi's sarcoma-associated herpesvirus.
Poole LJ; Yu Y; Kim PS; Zheng QZ; Pevsner J; Hayward GS
J Virol; 2002 Apr; 76(7):3395-420. PubMed ID: 11884566
[TBL] [Abstract][Full Text] [Related]
19. Primary B Lymphocytes Infected with Kaposi's Sarcoma-Associated Herpesvirus Can Be Expanded In Vitro and Are Recognized by LANA-Specific CD4+ T Cells.
Nicol SM; Sabbah S; Brulois KF; Jung JU; Bell AI; Hislop AD
J Virol; 2016 Apr; 90(8):3849-3859. PubMed ID: 26819313
[TBL] [Abstract][Full Text] [Related]
20. Covalent modification by SUMO is required for efficient disruption of PML oncogenic domains by Kaposi's sarcoma-associated herpesvirus latent protein LANA2.
Marcos-Villar L; Campagna M; Lopitz-Otsoa F; Gallego P; González-Santamaría J; González D; Rodriguez MS; Rivas C
J Gen Virol; 2011 Jan; 92(Pt 1):188-94. PubMed ID: 20881090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
